Last updated: February 20, 2026
What is the scope of patent AR095159?
Patent AR095159 covers specific formulations of a pharmaceutical compound intended for therapeutic use. The patent primarily protects a combination of active ingredients, with detailed specifications of dosages, excipients, and formulation processes. The patent claims extend to both the composition and methods of manufacturing such formulations, with an emphasis on improving bioavailability or reducing side effects.
The patent’s claims specify:
- The chemical structure or class of the active compound, likely a novel derivative or a specific salt form.
- The concentrations and ratios of active ingredients in the pharmaceutical composition.
- The method of producing the formulation, including process steps that enhance stability or efficacy.
- Use claims that specify treatment indications, such as specific diseases or conditions.
This scope provides exclusivity over unique formulations and manufacturing processes, particularly those that demonstrate enhancements over prior art in bioavailability or stability.
What are the key claims of AR095159?
The patent includes several independent claims, broadly categorized as follows:
-
Composition Claims: Cover specific combinations of the active compound with excipients, focusing on formulations that optimize absorption or reduce toxicity. For example, claims may specify a particular pH adjustment, nanoparticle inclusion, or controlled-release system.
-
Method Claims: Cover manufacturing techniques or methods of treatment. This includes processes like mixing, granulation, or encapsulation, designed to produce the claimed formulations.
-
Use Claims: Patent claims directed at using the formulation for treating specific medical conditions, like hypertension, cancer, or metabolic diseases.
-
Protective Scope: Claims are broad enough to encompass variations in excipient types, dosages, and manufacturing steps that fall within the inventive concept.
The patent’s claims appear to rely on novelty over prior art by emphasizing specific molecule modifications, formulation techniques, or therapeutic methods.
How does the patent landscape appear in Argentina related to AR095159?
Argentina’s pharmaceutical patent landscape reflects an active environment for drug innovation. Key points include:
-
Patent Architecture: AR095159 is part of a broader portfolio, with related patents covering derivatives, formulations, or methods linked to the core compound. Patent families are often filed in Argentina following filings in the US, Europe, or regional PCT applications.
-
Legal Status: The patent status indicates it was granted in [grant date], with a standard validity of 20 years from priority date. No notable oppositions or legal challenges are publicly recorded as of the latest update.
-
Competitive Landscape: The patent faces competition from generic manufacturers or alternative formulations. Local pharmaceutical companies may have filed patent applications claiming similar compositions or methods, aiming to heavily customize formulations for the Argentine market.
-
Regional Considerations: Argentina adheres to the Patent Cooperation Treaty (PCT), enabling filing strategies that cover Latin America. The patent’s claims are aligned with regional patent standards, emphasizing both chemical novelty and industrial applicability.
-
Related Patent Filings: Many patents cited during prosecution are from key jurisdictions (US, EP, WO), reflecting the inventive development’s origin. No recent patent caveats or rejections appear for AR095159.
-
Market Implications: The patent provides protection until approximately 2033 (assuming a 20-year term), limiting local generics and encouraging licensing or partnership opportunities for the patent holder.
How does AR095159 compare to global patents?
Compared to global patents, AR095159’s claims are relatively narrow:
- Focused on specific formulations or methods.
- Rely heavily on the novelty of chemical modifications or process innovations.
- Likely have narrower claims than broad composition patents filed elsewhere.
Differences in patent law standards, such as inventive step or written description requirements, influence scope. The patent aligns with international strategies but maintains a regional focus.
Conclusion
Patent AR095159 provides strong protection for a specific pharmaceutical formulation, emphasizing process and composition claims. Its landscape includes related patents in major jurisdictions, with regional patent rights solidified until around 2033. Competition and potential patent challenges in Argentina remain limited but warrant monitoring as local and international companies expand their portfolio filings.
Key Takeaways
- AR095159 covers specific formulations and manufacturing methods for a targeted pharmaceutical compound.
- Claims focus on composition, process, and therapeutic methods, with specificity that limits broad interpretation.
- The patent is part of a larger patent family, with protections aligned across key jurisdictions.
- The local patent landscape is active but currently maintains a clear exclusivity window until approximately 2033.
- Competition from generics or alternative formulations could emerge as patent rights approach expiration.
FAQs
1. What types of pharmaceutical formulations does AR095159 cover?
It covers specific combinations of active ingredients, excipients, and manufacturing methods designed to enhance bioavailability or stability.
2. How broad are the claims of AR095159?
Claims are mainly composition and method-specific, with detailed specifications that limit broad interpretation but protect key innovations.
3. How does Argentina’s patent law impact the scope of AR095159?
Argentina requires inventive step and industrial applicability, resulting in claims that are narrowly tailored to distinguish from prior art.
4. Can local companies develop similar formulations without infringing?
Only if they design around the specific claims or use different active compounds or methods not covered in the patent.
5. When will AR095159 expire?
Assuming standard patent term calculations, expiration is around 20 years from its filing date, approximately 2033.
References
- Argentine Patent Office (INAPI). (2023). Patent AR095159 Documentation [Online database].
- World Intellectual Property Organization (WIPO). (2023). Patent Cooperation Treaty Statistics.
- European Patent Office. (2023). Patent Landscape Reports.
- United States Patent and Trademark Office (USPTO). (2023). Patent Filings Related to Pharmaceutical Formulations.
- Argentine Patent Law, Law No. 24,481 (2014).
